Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania
Wael Mansour(Universität Hamburg), Françoise Lunel(Centre Hospitalier Universitaire d'Angers), Frédéric Le Gal(Sorbonne Université), Cheikh-Tijani Hamed(Centre National de Lutte Antiacridienne), Alexandra Ducancelle, Ségolène Brichler(Inserm), M. Rosenheim(Sorbonne Université), Emmanuel Gordien(Inserm), Baïdy Lô(Université de Nouakchott), Mohamed-Abdellahi Bollahi(Centre National de Lutte Antiacridienne)
Cited by 47
Related Papers
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a <i>Deltavirus</i> Genus of at Least Seven Major Clades
|Journal of Virology|2004|221
Eighth Major Clade for Hepatitis Delta Virus
|Emerging infectious diseases|2006|206